Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,902.00    -68.00 (-1.71%)
Bid:
3,904.00
Ask:
3,908.00
Spread: 4.00 (0.102%)
Market Cap: £14.74b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Directorate Change

11 Nov 2011 07:00

RNS Number : 9045R
Halma PLC
11 November 2011
 



HALMA p.l.c.

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

 

Halma, the leading safety, health and sensor technology group, announces the appointment of Daniela Barone Soares as a non-executive Director of the Company with effect from 10 November 2011. She will join the Audit Committee.Daniela Barone Soares is Chief Executive of Impetus Trust, the pioneer venture philanthropists in the UK; this is an organisation that translates venture capital principles to the social sector. Her past business roles have included Head of Institutional Support at Save the Children, Assistant Vice President, Private Equity and Venture Capital at BancBoston Capital, Inc. and roles at Goldman, Sachs & Co. (New York) and Citibank, N.A. (Brazil).

 

Daniela is also on the advisory board or a trustee of a number of non-listed, social sector organisations in the UK and Brazil. She has a BSc in Economics from Universidade Estadual de Campinas (UNICAMP), Brazil and an MBA from Harvard Business School.

 

Geoff Unwin, Chairman of Halma, commenting on the appointment:

"I am delighted to announce that Daniela Barone Soares has agreed to join the Halma Board.

 

"The Board continually keeps the appropriateness of its composition under review particularly in terms of relevant experience and diversity in its widest sense. Daniela's experience demonstrates this commitment threefold - geographically, in terms of gender and by way of executive experience. Daniela will certainly add to the Board's debate on value creation with her unique perspective.

 

Note: There are no further details to disclose pursuant to Listing Rule 9.6.13.

 

 

For further information, please contact:

Andrew Williams, Chief ExecutiveHalma p.l.c.

 

+44 (0)1494 721111

MHP CommunicationsRachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

 

Notes to the Editor

 

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises three business sectors:

 

·; Health and Analysis

Products used to improve personal and public health. We develop technologies for analysis in safety, life sciences and environmental markets.

 

·; Infrastructure Sensors

Products which detect hazards to protect assets and people in public and commercial buildings.

 

·; Industrial Safety

Products which protect assets and people at work.

 

The key characteristics of Halma's businesses are that they are based on advanced technology and offer strong growth potential. Many Group businesses are clear market leaders in their specialist field and, in a number of cases, are the dominant world supplier.

 

 

Impetus Trust (www.impetus.org.uk) works to break the cycle of poverty by investing in ambitious charities and social enterprises that fight economic disadvantage. It uses a highly effective venture philanthropy model to accelerate the growth of carefully selected organisations so they can help more economically disadvantaged people to gain education, skills and jobs.

 

Organisations backed by Impetus Trust are helping more than 250,000 people to escape the cycle of poverty.

 

In April 2011, Impetus, together with education charity The Sutton Trust, was chosen to manage the £125 million Education Endowment Foundation, backed by the Department for Education, to raise educational attainment of disadvantaged children in England.

 

More information about how Impetus works with the charities and social enterprises in its portfolio, and the impact it is having, may be viewed on its website: http://www.impetus.org.uk/what's-special-about-impetus/our-innovative-approach/.

 

 

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMMMMNGDGMZM
Date   Source Headline
23rd Jun 20262:39 pmRNSDirector/PDMR Shareholding
16th Jun 20263:36 pmRNSDirector/PDMR Shareholding
16th Jun 20269:19 amRNSDirector Declaration
12th Jun 20264:03 pmRNSDirectorate change
11th Jun 20267:00 amRNSFull Year Results
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.